CASPOFUNGIN ACETATE FOR INJECTION 50 MG/VIAL

Indications

• Invasive candidiasis
• Invasive aspergillosis
• Empirical treatment of systemic fungal infections in patients with neutropenia

Dosage

Adults: For adults with a body weight up to 81 kg: Loading dose of 70 mg once daily for 1 day, then maintenance dose of 50 mg once daily. For adults with a body weight

Mechanism of action

Caspofungin inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of the cell wall of Aspergillus and Candida species. This inhibition occurs through the blockade of the enzyme beta-(1,3)-glucan synthase, which is crucial for fungal cell wall integrity. The absence of beta-(1,3)-D-glucan in mammalian cells means that Caspofungin selectively targets fungal cells while sparing human cells.

Pharmacodynamics

As an antifungal agent, Caspofungin has shown efficacy against various strains of Candida and Aspergillus. By inhibiting cell wall synthesis, it disrupts fungal growth and replication. While resistance can develop through mutations in the FKS1 gene, in vitro studies have not shown significant resistance development in Aspergillus species to Caspofungin, indicating good efficacy in treating these infections.

Pharmacokinetics

Caspofungin is administered intravenously and has a pharmacokinetic profile characterized by extensive protein binding (about 97%). It is metabolized primarily in the liver and does not undergo significant renal clearance. The drug has a half-life of approximately 9 to 11 hours, allowing for once-daily dosing after the initial loading dose. Its pharmacokinetics may be influenced by factors such as liver function and co-administration with other medications.

Adverse effects

• Nausea
• Vomiting
• Fever
• Rash
• Hypotension
• Elevated liver enzymes
• Anemia
• Headache

Interactions

• Efavirenz: moderate decrease in concentration
• Nevirapine: moderate decrease in concentration
• Ciclosporin: unknown effect on exposure
• Dexamethasone: unknown decrease in concentration
• Rifampicin: unknown decrease in concentration

Precautions

• Liver dysfunction should be monitored due to potential hepatotoxicity
• Hypersensitivity reactions could occur; monitor for signs
• Use with caution in patients with renal impairment
• Monitor for infusion-related reactions

Pregnancy

Manufacturer advises to avoid unless potential benefit outweighs risk; toxicity observed in animal studies.

Breast-feeding

Manufacturer advises to avoid unless potential benefit outweighs risk; present in milk in animal studies.

Storage

Store at room temperature, protect from light. Reconstituted solution should be used immediately or stored at 2-8°C for 24 hours.

Formulations

• Caspofungin 50 mg powder for solution for infusion
• Caspofungin 70 mg powder for solution for infusion

Dosage

Children: Refer to specific drug guidelines for pediatric dosing based on the units of measurement applicable to that drug.

Adults: Refer to specific drug guidelines for dosing based on the units of measurement applicable to that drug.

Mechanism of action

The mechanism of action for any drug labeled as a 'unit' would depend on the specific drug in question. Generally, a unit may refer to the potency of a drug, indicating how much of a drug is required to produce a therapeutic effect. For example, insulin units refer to the amount of insulin needed to lower blood glucose levels effectively.

Pharmacodynamics

Pharmacodynamics relates to the effects of a drug on the body. For drugs measured in units, pharmacodynamics can vary significantly. For instance, in the case of insulin, it acts by facilitating the uptake of glucose into cells, thereby reducing blood sugar levels. The relationship between dose (measured in units) and effect can be described by dose-response curves.

Pharmacokinetics

Pharmacokinetics encompasses the absorption, distribution, metabolism, and excretion of drugs. The pharmacokinetic profile of a drug measured in units will depend on the specific drug. For example, insulin is rapidly absorbed after subcutaneous injection, with a peak effect typically occurring within 1 to 3 hours, and it is metabolized primarily in the liver and kidneys.

Pregnancy

Consult healthcare professional, as safety data may be limited.

Breast-feeding

Consult healthcare professional, as safety data may be limited.

Storage

Store in a cool, dry place, away from direct sunlight.

Mechanism of action

Caspofungin inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of the cell wall of <i>Aspergillus</i> species and <i>Candida</i> species. beta-(1,3)-D-glucan is not present in mammalian cells. The primary target is beta-(1,3)-glucan synthase. Caspofungin inhibits the synthesis of beta(1,3)-d-glucan, an integral component of the fungal cell wall that is not present in mammalian cells. Caspofungin acetate ... /belongs to a class of drugs/ referred to as echinocandins, which inhibit the formation of beta(1,3)-D-glucans in the fungal cell wall. Resistance is conferred by mutations in the FKS1 gene, which codes for a large subunit of (1,3)beta-glucan synthase. /Caspofungin acetate/ Caspofungin acetate, the active ingredient of cancidas, inhibits the synthesis of alpha(1,3)-D-glucan, an essential component of the cell wall of susceptible Aspergillus species and Candida species. (1,3)-D-glucan is not present in mammalian cells. Caspofungin has shown activity against Candida species and in regions of active cell growth of the hyphae of Aspergillus fumigatus. /Caspofungin acetate/

Pharmacodynamics

Caspofungin is an antifungal drug, and belongs to a new class termed the echinocandins. It is used to treat <i>Aspergillus</i> and <i>Candida</i> infection, and works by inhibiting cell wall synthesis. Antifungals in the echinocandin class inhibit the synthesis of glucan in the cell wall, probably via the enzyme 1,3-beta glucan synthase. There is a potential for resistance development to occur, however <i>in vitro</i> resistance development to Caspofungin by Aspergillus species has not been studied.